Global Sleep Apnea Diagnostic And Therapeutic Devices Industry

• Publication date: October 2012
• Report size: 399 pages

This report analyzes the worldwide markets for Sleep Apnea Diagnostic and Therapeutic Devices in US$ Million by the following Product Segments: Diagnostic Devices (Fixed PSG, Ambulatory PSG, & Others (include Screening Devices)), and Therapeutic Devices (CPAP, Bi-Level PAP, Auto PAP, & Facial Interfaces (Masks and Humidifiers)). The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and...

This report analyzes the worldwide markets for Sleep Apnea Diagnostic and Therapeutic Devices in US$ Million by the following Product Segments: Diagnostic Devices (Fixed PSG, Ambulatory PSG, & Others (include Screening Devices)), and Therapeutic Devices (CPAP, Bi-Level PAP, Auto PAP, & Facial Interfaces (Masks and Humidifiers)). The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 68 companies including many key and niche players such as Grass Technologies, Cadwell Laboratories, Inc., CareFusion Corporation, Compumedics Ltd., DeVilbiss Healthcare, Global Medical Holdings LLC, Fisher & Paykel Healthcare Limited, GE Healthcare, Vital Signs Inc., Itamar Medical Ltd., Invacare Corporation, Natus Medical Inc., Bio-Logic, Embla Systems, Inc., Stellate Systems, Inc., Philips Healthcare, ResMed Inc., Teleflex Medical, and Weinmann Geräte für Medizin GmbH+CCo. KG. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Pathology Industry in Europe

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Diagnostic Devices I-3
Fixed PSG I-3
Ambulatory PSG I-3
Others (include Screening Devices) I-3
Therapeutic Devices I-4
CPAP I-4
Bi-Level PAP I-4
Auto PAP I-4
Facial Interfaces (Masks and Humidifiers) I-4


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW II-1
Current & Future Analysis II-1
Prevalence Statistics II-1
The US is the Clear Market Leader, Developing Regions Promise
Growth II-2
Segmental Analysis II-2

2. MARKET DYNAMICS II-3
Impact of Economic Recession on the Medical Device Industry II-3
Emergence of Dental Sleep Medicine II-3
Sleep Apnea/Sleep Disorders in Children Responsible for Obesity II-3
Changing Demographics to Play a Major Role II-4
Increased Awareness of Comorbid Conditions Spurs Market Growth II-4
Demerits of Present Diagnostic Procedures II-4
Technology Advancements Improve Patient Compliance II-4
Automated CPAP II-5
Humidification II-5
Patient-Friendly Masks II-5
Educational Campaigns II-5
Under-Penetration in CPAP Therapy Promises Significant Growth
Prospects II-5
OSA Industry Witnesses Consistent M&A Activity II-5

3. COMPETITION AND MARKET STRUCTURE II-7
Resmed and Respironics Dominate Competitive Landscape II-7
Table 1: Global Sleep Apnea Market by Leading Players (2011):
Market Share Breakdown for Philips Respironics, Resmed,
Fisher & Paykel, General Electric Vital Signs, and Others
(includes corresponding Graph/Chart) II-7

Table 2: Global Sleep Apnea Diagnostic Systems Market by
Leading Players: Market Share Breakdown for CareFusion Corp.,
Philips Respironics, Embla Systems, and Others (includes
corresponding Graph/Chart) II-7

4. SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES - A SYNOPSIS II-8
Significance of Sleep II-8
Stages of Sleep II-8
Sleep Disorders and Stages of Sleep II-8
Sleep Apnea- Introduction II-8
Forms of Apnea II-9
Central Sleep Apnea II-9
Physiological Effects of CSA II-9
Mixed Apnea II-9
Complex Sleep Apnea II-9
Obstructive Sleep Apnea - An Overview II-10
History II-10
Causes of OSA II-10
Symptoms of OSA II-11
Snoring and OSA II-11
Risks and Complications Associated with Untreated Disorder II-11
Risk Groups II-11
Co-Morbid Conditions II-12
Heart Failure II-12
Hypertension II-12
Diabetes II-12
Fatigue II-12
Complications Associated with Surgery and Medications II-12
Financial Implications of Untreated OSA II-13
Pediatric OSA II-13

5. SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES II-14
OSA Diagnosis II-14
Interpreting AHI II-14
AHI of 5 to 15: Mild OSA II-14
AHI of 15 to 30: Moderate OSA II-14
AHI of more than 30: Severe OSA II-14
Sleep Apnea Diagnostic Devices II-14
Polysomnography (PSG), and Types of Polysomnographs II-14
Clinical/Fixed Polysomnographs II-15
Ambulatory Polysomnographs II-15
Other Sleep Apnea Diagnostic Devices II-16
Screening Devices II-16
Actigraphs II-16
Sleep Apnea Therapeutic Devices II-16
Positive Airway Pressure (PAP) Treatment II-16
PAP Devices II-16
Continuous Positive Airway Pressure (CPAP) Devices II-16
Optional Features Available for CPAP Devices II-17
Bilevel Positive Airway Pressure (BiPAP) Devices II-17
Auto-titrating Positive Airway Pressure (APAP) Devices II-18
Facial Interfaces (Masks and Humidifiers) II-18
Alternative Apnea Therapies II-18
Oral Appliances II-18
Surgical Procedures II-19
Tracheostomy II-19
Uvulo-palato-pharyngoplasty (UPPP) II-19
Mandibular Myotomy II-19
Laser Assisted Uvuloplasty (LAUP) II-19
Somnoplasty or Radio Frequency (RF) Procedure II-19
Pillar Palatal Implant System II-20
Other Surgical Therapies II-20
Over-the-Counter and Pharmacological Therapies II-20
Behavioral and Lifestyle Changes II-20

6. RESEARCH FINDINGS II-21
Research Finds Link Between Sleep Apnea and Heart Risks in
Children II-21
Sleep Disorders Increase Risk for Stroke and Blood Pressure
Patients II-21
Individuals with Sleep Apnea Face Greater Risk of Cardiac
Stress During Air Travel II-21
Sleep Apnea Screening Reduces Risk of Post Operative
Complications II-21

7. PRODUCT LAUNCHES/INTRODUCTIONS II-22
US Researchers Develop Novel Sleep Apnea Diagnostic Device
Based on Ultrasonic Sensors II-22
NovaSom Introduces MediTrack® II-22
ResMed Launches S9 Series for Sleep Apnea Therapy II-22
GE Healthcare Launches MARS® Virtual Sleep Lab II-23
Remote Analysis Launches iPhone Sleep Diagnostic Application II-23
Circadiance Unveils New Zzzephyr Seal II-23
Philips Launches New Sleep Therapy System II-24
ImThera Medical Unveils aura6000TM Neurostimulation System II-24
Philips Unveils Respironics Products in India II-24
CardioNet Introduces SomNet Cardiac Indicator II-24
FDA Grants 510(K) Clearance to Dormio Tech II-24
Ambu Acquires Sleepmate Technologies II-25
CIRCADIANTM Enters into Partnership with Sleep PointeTM for
Providing OSA Detection and Cure II-25
Medtronic Acquires Restore Medical II-25
Blackstone to Take Over Apria Healthcare II-25
Nihon Kohden Acquires Neurotronics II-25
Medtronic Snaps Up Repose GAHM Product Line of InfluENT Medical II-26
GE Healthcare Acquires Vital Signs II-26
CleveMed Enters into Collaboration with BIDMC Professor II-26
Royal Philips Acquires Respironics II-26
Cardinal Health Signs Agreement with SleepNet II-27
Nihon Kohden Signs New Agreement with Premier II-27

8. RECENT INDUSTRY ACTIVITY II-28
Dehaier Obtains CE Certification for Sleep Diagnostic Devices
and Air Compressors II-28
CareCentrix Takes Over Sleep Management Solutions II-28
Natus Snaps Up Embla Systems II-28
Graymark Acquires Majority Stake in Village Sleep Center II-29
Continucare Expands Operations through Acquisitions II-29
Healthcare of Today to Acquire IMA and SC X-Ray II-29
Cyberonics Invests in ImThera, Acquires Minority Interest II-30
Graymark Healthcare and North Oak Medical Park Form Partnership II-30
Graymark Healthcare Sells Nocturna East Sleep Centers II-31
Watermark Medical Collaborates with AASM for OSA Diagnostic-
Care Study II-31
AZ-TMJ Sets Up Sleep Apnea Treatment Unit II-31
Phyhealth Launches Subsidiary Phyhealth Sleep Care Centre II-31
WideMed Receives CE Certification for Mobile Sleep Apnea System II-32
WideMed Receives Order from GE Healthcare for Morpheus Hx Devices II-32
SleepQuest Buys Extra WatchPAT Devices from Itamar-Medical II-32
Coliseum Northside Hospital Opens Sleep Disorder Center II-32
Naturs Design Signs Partnership with Intus Healthcare II-33
Graymark Healthcare and Coryell Memorial Healthcare Ink Agreement II-33
Compumedics Obtains FDA Approval for GRAEL™ HD-PSG Sllep System II-33
Covidien Sells Sleep Therapy and Bi-level Products to PH Invest II-33
Embla Snaps Up Covidien's Sleep Diagnostic Business II-33
Graymark Healthcare Signs Joint Venture Agreement with
Oklahoma Heart Hospital II-34
Ethicon Takes Over Acclarent II-34
Siix to Develop Sleep Disorders Tracking Device II-34
Blue Shield and Apria Healthcare Ink Agreement Group II-34
Peak Surgical Inks Distribution Agreement with Medtronic II-34
REM Medical, U.S. Health Works Enter into Partnership II-35
Graymark Healthcare Takes Over somniTech and somniCare II-35
ResMed Takes Over Laboratoires Narval II-35
Curative Medical Snaps Up BEVT II-35
Roadside Medical Clinic + Lab Enters into Joint Venture with
Sleep Pointe II-35
Air Liquide Takes Over Comcare Medical II-36
REM Medical Takes Over Tucson Site of PsyPharma Global II-36
Formation of CareFusion II-36

9. FOCUS ON SELECT PLAYERS II-37
Grass Technologies (US) II-37
Cadwell Laboratories, Inc. (US) II-37
CareFusion Corporation (USA) II-37
Compumedics Ltd (Australia) II-38
DeVilbiss Healthcare (US) II-38
Global Medical Holdings LLC (US) II-39
Fisher & Paykel Healthcare Limited (New Zealand) II-39
GE Healthcare (US) II-39
Vital Signs Inc. (US) II-39
Itamar Medical Ltd. (Israel) II-40
Invacare Corporation (US) II-40
Natus Medical Inc. (US) II-40
Bio-Logic (US) II-40
Embla Systems, Inc. (US) II-41
Stellate Systems, Inc. (Canada) II-41
Philips Healthcare (USA) II-41
ResMed Inc. (US) II-42
Teleflex Medical (US) II-42
Weinmann Geräte für Medizin GmbH+CCo. KG (Germany) II-42

10. GLOBAL MARKET PERSPECTIVE II-43
Table 3: World Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Geographic
Region - US, Japan, Europe and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2010 through 2018 (includes corresponding Graph/Chart) II-43

Table 4: World Historic Review for Sleep Apnea Diagnostic and
Therapeutic Devices by Geographic Region - US, Japan, Europe
and Rest of World Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-44

Table 5: World 15-Year Perspective for Sleep Apnea Diagnostic
and Therapeutic Devices by Geographic Region - Percentage
Breakdown of Value Sales for US, Japan, Europe and Rest of
World Markets for Years 2004, 2011, and 2018 (includes
corresponding Graph/Chart) II-45

Table 6: World Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic Devices by Geographic Region - US,
Japan, Europe and Rest of World Markets Independently Analyzed
with Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) II-46

Table 7: World Historic Review for Sleep Apnea Diagnostic
Devices by Geographic Region - US, Japan, Europe and Rest of
World Markets Independently Analyzed with Annual Sales in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-47

Table 8: World 15-Year Perspective for Sleep Apnea Diagnostic
Devices by Geographic Region - Percentage Breakdown of Value
Sales for US, Japan, Europe and Rest of World Markets for
Years 2004, 2011, and 2018 (includes corresponding
Graph/Chart) II-48

Table 9: World Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic Devices by Product Segment -
Clinical/Fixed PSG, Ambulatory PSG, and Other Devices
(Screening Devices) Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-49

Table 10: World Historic Review for Sleep Apnea Diagnostic
Devices by Product Segment - Clinical/Fixed PSG, Ambulatory
PSG, and Other Devices (Screening Devices) Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) II-50

Table 11: World 15-Year Perspective for Sleep Apnea Diagnostic
Devices by Product Segment - Percentage Breakdown of Value
Sales for Clinical/Fixed PSG, Ambulatory PSG, and Other
Devices (Screening Devices) Markets for Years 2004, 2011, and
2018 (includes corresponding Graph/Chart) II-51

Table 12: World Recent Past, Current & Future Analysis for
Clinical/Fixed PSG Devices by Geographic Region - US, Japan,
Europe and Rest of World Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) II-52

Table 13: World Historic Review for Clinical/Fixed PSG Devices
by Geographic Region - US, Japan, Europe and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-53

Table 14: World 15-Year Perspective for Clinical/Fixed PSG
Devices by Geographic Region - Percentage Breakdown of Value
Sales for US, Japan, Europe and Rest of World Markets for
Years 2004, 2011, and 2018 (includes corresponding
Graph/Chart) II-54

Table 15: World Recent Past, Current & Future Analysis for
Ambulatory PSG Devices by Geographic Region - US, Japan,
Europe and Rest of World Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) II-55

Table 16: World Historic Review for Ambulatory PSG Devices by
Geographic Region - US, Japan, Europe and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-56

Table 17: World 15-Year Perspective for Ambulatory PSG Devices
by Geographic Region - Percentage Breakdown of Value Sales for
US, Japan, Europe and Rest of World Markets for Years 2004,
2011, and 2018 (includes corresponding Graph/Chart) II-57

Table 18: World Recent Past, Current & Future Analysis for
Other Diagnostic Devices (Screening Devices) by Geographic
Region - US, Japan, Europe and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2010 through 2018 (includes corresponding Graph/Chart) II-58

Table 19: World Historic Review for Other Diagnostic Devices
(Screening Devices) by Geographic Region - US, Japan, Europe
and Rest of World Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-59

Table 20: World 15-Year Perspective for Other Diagnostic
Devices (Screening Devices) by Geographic Region - Percentage
Breakdown of Value Sales for US, Japan, Europe and Rest of
World Markets for Years 2004, 2011, and 2018 (includes
corresponding Graph/Chart) II-60

Table 21: World Recent Past, Current & Future Analysis for
Sleep Apnea Therapeutic Devices by Geographic Region - US,
Japan, Europe and Rest of World Markets Independently Analyzed
with Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) II-61

Table 22: World Historic Review for Sleep Apnea Therapeutic
Devices by Geographic Region - US, Japan, Europe and Rest of
World Markets Independently Analyzed with Annual Sales in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-62

Table 23: World 15-Year Perspective for Sleep Apnea
Therapeutic Devices by Geographic Region - Percentage
Breakdown of Value Sales for US, Japan, Europe and Rest of
World Markets for Years 2004, 2011, and 2018 (includes
corresponding Graph/Chart) II-63

Table 24: World Recent Past, Current & Future Analysis for
Sleep Apnea Therapeutic Devices by Product Segment - PAP, Auto
PAP, Bi-Level CPAP, and Facial Interfaces (Masks and
Humidifiers) Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-64

Table 25: World Historic Review for Sleep Apnea Therapeutic
Devices by Product Segment - CPAP, Auto PAP, Bi-Level PAP, and
Facial Interfaces (Masks and Humidifiers) Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) II-65

Table 26: World 15-Year Perspective for Sleep Apnea
Therapeutic Devices by Product Segment - Percentage Breakdown
of Value Sales for CPAP, Auto PAP, Bi-Level PAP, and Facial
Interfaces (Masks and Humidifiers) Markets for Years 2004,
2011, and 2018 (includes corresponding Graph/Chart) II-66

Table 27: World Recent Past, Current & Future Analysis for
CPAP Devices by Geographic Region - US, Japan, Europe and Rest
of World Markets Independently Analyzed with Annual Sales in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-67

Table 28: World Historic Review for CPAP Devices by Geographic
Region - US, Japan, Europe and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) II-68

Table 29: World 15-Year Perspective for CPAP Devices by
Geographic Region - Percentage Breakdown of Value Sales for
US, Japan, Europe and Rest of World Markets for Years 2004,
2011, and 2018 (includes corresponding Graph/Chart) II-69

Table 30: World Recent Past, Current & Future Analysis for
Auto PAP Devices by Geographic Region - US, Japan, Europe and
Rest of World Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-70

Table 31: World Historic Review for Auto PAP Devices by
Geographic Region - US, Japan, Europe and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-71

Table 32: World 15-Year Perspective for Auto PAP Devices by
Geographic Region - Percentage Breakdown of Value Sales for
US, Japan, Europe and Rest of World Markets for Years 2004,
2011, and 2018 (includes corresponding Graph/Chart) II-72

Table 33: World Recent Past, Current & Future Analysis for
Bi-Level PAP Devices by Geographic Region - US, Japan, Europe
and Rest of World Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-73

Table 34: World Historic Review for Bi-Level PAP Devices by
Geographic Region - US, Japan, Europe and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-74

Table 35: World 15-Year Perspective for Bi-Level PAP Devices
by Geographic Region - Percentage Breakdown of Value Sales for
US, Japan, Europe and Rest of World Markets for Years 2004,
2011, and 2018 (includes corresponding Graph/Chart) II-75

Table 36: World Recent Past, Current & Future Analysis for
Facial Interfaces (Masks and Humidifiers) by Geographic Region -
US, Japan, Europe and Rest of World Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) II-76

Table 37: World Historic Review for Facial Interfaces (Masks
and Humidifiers) by Geographic Region - US, Japan, Europe and
Rest of World Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-77

Table 38: World 15-Year Perspective for Facial Interfaces
(Masks and Humidifiers) by Geographic Region - Percentage
Breakdown of Value Sales for US, Japan, Europe and Rest of
World Markets for Years 2004, 2011, and 2018 (includes
corresponding Graph/Chart) II-78


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Sleep Disorders: Factsheet III-1
Sleep Apnea in the US: A Demographic Outline III-1
Sleep Apnea Devices: Overview III-1
Sleep Apnea Market Flourishes under the Influence of Myriad
Factors III-2
Home Sleep Testing (HST) III-2
Pricing Trends III-3
Pricing Erosion on the Rise III-3
Premium Products to Command Higher Prices III-3
Reimbursement Scenario III-3
Reimbursement Revisions to Boost OSA Market III-3
Home Sleep Tests Pose Significant Risk for Clinical
Polysomnographs III-4
Reimbursement Criteria for Sleep Apnea Diagnostic and
Therapy Devices III-4
Table 39: Reimbursement Rates of CPAP Devices: 2010 (In
US$) III-5
Average Replacement Schedules III-6
Competitive Landscape III-6
Table 40: US Market for Sleep Therapy (2011) - Percentage
Breakdown of Revenues for Respironics, ResMed, Fisher &
Paykel, and Others III-6
Distribution of Sleep Apnea Devices III-6
A Review of the Sleep Service Providers Market III-7
Greater Awareness Drives More Number of Sleep Labs III-7
Table 41: Increasing Number of Sleep Facilities in the US
(includes corresponding Graph/Chart) III-7
Changeover of the Sleep Lab III-8
Inadequate Sleep Labs - a Bottleneck for Diagnosis of OSA III-8
Inadequate Sleep Labs Surge Development of Portable Sleep
Monitoring III-8
DME Market for Sleep Apnea Devices III-9
Table 42: US Market for CPAP Devices (2010) - Percentage
Breakdown of Value Sales by Durable Medical Equipment (DME)
Suppliers for Apria Healthcare Group, Lincare Holdings Inc,
National Companies and Local Operators (includes
corresponding Graph/Chart) III-9
Strategic Corporate Developments III-9
Focus on Select Players III-13
B.Market Analytics III-18
Table 43: The US Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment - Diagnostic Devices (Clinical/Fixed PSG, Ambulatory
PSG, and Others (Screening Devices)), and Therapeutic
Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces
(Masks and Humidifiers)) Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-18

Table 44: The US Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment - Diagnostic
Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others
(Screening Devices)), and Therapeutic Devices (CPAP ,Auto
PAP, Bi-Level PAP, and Facial Interfaces (Masks and
Humidifiers)) Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-19

Table 45: The US 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
(Clinical/ Fixed PSG, Ambulatory PSG, and Others (Screening
Devices)), and Therapeutic Devices (CPAP, Auto PAP,Bi-Level
PAP, and Facial Interfaces (Masks and Humidifiers)) Markets
for Years 2004, 2011, and 2018 (includes corresponding
Graph/Chart) III-20

2. JAPAN III-21
A.Market Analysis III-21
Japanese Continuous-Positive Airway Pressure (CPAP) Market III-21
B.Market Analytics III-22
Table 46: Japanese Recent Past, Current & Future Analysis
for Sleep Apnea Diagnostic and Therapeutic Devices by
Product Segment - Diagnostic Devices (Clinical/Fixed PSG,
Ambulatory PSG, and Others (Screening Devices)), and
Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and
Facial Interfaces (Masks and Humidifiers)) Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2010 through 2018 (includes corresponding Graph/Chart) III-22

Table 47: Japanese Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and
Others (Screening Devices)), and Therapeutic Devices (CPAP,
Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and
Humidifiers)) Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-23

Table 48: Japanese 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and
Others (Screening Devices)), and Therapeutic Devices (CPAP,
Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and
Humidifiers)) Markets for Years 2004, 2011, and 2018
(includes corresponding Graph/Chart) III-24

3. EUROPE III-25
A.Market Analysis III-25
Sleep Apnea Diagnostics - Overview III-25
Trends & Issues III-26
Ambulatory PSGs Gaining over Clinical PSGs III-26
Insufficient Funds & Improper Distribution Endanger Growth
of Sleep Apnea Diagnostics III-26
Strategic Corporate Initiatives III-26
B.Market Analytics III-28
Table 49: European Recent Past, Current & Future Analysis
for Sleep Apnea Diagnostic and Therapeutic Devices by
Geographic Region - France, Germany, Italy, UK, Spain and
Rest of Europe Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-28

Table 50: European Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Geographic Region -
France, Germany, Italy, UK, Spain and Rest of Europe Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-29

Table 51: European 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Geographic Region -
Percentage Breakdown of Value Sales for France, Germany,
Italy, UK, Spain and Rest of Europe Markets for Years 2004,
2011, and 2018 (includes corresponding Graph/Chart) III-30

Table 52: European Recent Past, Current & Future Analysis
for Sleep Apnea Diagnostic and Therapeutic Devices by
Product Segment - Diagnostic Devices (Clinical/Fixed PSG,
Ambulatory PSG, and Others (Screening Devices)), and
Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and
Facial Interfaces (Masks and Humidifiers)) Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2010 through 2018 (includes corresponding Graph/Chart) III-31

Table 53: European Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and
Others (Screening Devices)), and Therapeutic Devices (CPAP,
Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and
Humidifiers)) Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-32

Table 54: European 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
(Clinical/ Fixed PSG, Ambulatory PSG, and Others (Screening
Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level
PAP, and Facial Interfaces (Masks and Humidifiers)) Markets
for Years 2004, 2011, and 2018 (includes corresponding
Graph/Chart) III-33

3a. FRANCE III-34
A.Market Analysis III-34
Outlook III-34
B.Market Analytics III-35
Table 55: French Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea
Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-35

Table 56: French Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment - Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-36

Table 57: French 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets for Years 2004, 2011, and 2018 (includes
corresponding Graph/Chart) III-37

3b. GERMANY III-38
A.Market Analysis III-38
Weinmann Geräte für Medizin GmbH+CCo. KG - A Key Player III-38
B.Market Analytics III-39
Table 58: German Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea
Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-39

Table 59: German Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment - Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-40

Table 60: German 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets for Years 2004, 2011, and 2018 (includes
corresponding Graph/Chart) III-41

3c. ITALY III-42
Market Analysis III-42
Table 61: Italian Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea
Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-42

Table 62: Italian Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment - Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-43

Table 63: Italian 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets for Years 2004, 2011, and 2018 (includes
corresponding Graph/Chart) III-44

3d. THE UNITED KINGDOM III-45
A.Market Analysis III-45
Sleep Disorder: Factsheet III-45
Current and Future Analysis III-45
B.Market Analytics III-46
Table 64: The UK Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea
Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-46

Table 65: The UK Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment - Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-47

Table 66: The UK 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets for Years 2004, 2011, and 2018 (includes
corresponding Graph/Chart) III-48

3e. SPAIN III-49
Market Analysis III-49
Table 67: Spanish Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea
Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-49

Table 68: Spanish Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment - Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-50

Table 69: Spanish 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets for Years 2004, 2011, and 2018 (includes
corresponding Graph/Chart) III-51

3f. REST OF EUROPE III-52
Market Analysis III-52
Table 70: Rest of European Recent Past, Current & Future
Analysis for Sleep Apnea Diagnostic and Therapeutic Devices
by Product Segment - Sleep Apnea Diagnostic Devices and
Sleep Apnea Therapeutic Devices Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-52

Table 71: Rest of European Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic
Devices Markets Independently Analyzed with Annual Sales in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-53

Table 72: Rest of European 15-Year Perspective for Sleep
Apnea Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets for Years 2004, 2011, and 2018 (includes
corresponding Graph/Chart) III-54

4. REST OF WORLD III-55
A.Market Analysis III-55
Outlook III-55
Overview of Select Markets III-55
Australia III-55
Significant Demand for Sleep Apnea Therapeutic Devices III-55
Table 73: Australian Sleep Apnea Therapeutic Devices
Market (2011) - Percentage Breakdown of Value Sales for
ResMed, Respironics, Fisher & Paykel and Others (includes
corresponding Graph/Chart) III-56
Distribution III-56
Table 74: Australian Sleep Apnea Therapeutic Devices Market
by Distribution Channel: 2011 (includes corresponding
Graph/Chart) III-56
India - A High Potential Market III-56
Focus on Select Players III-57
B.Market Analytics III-59
Table 75: Rest of World Recent Past, Current & Future
Analysis for Sleep Apnea Diagnostic and Therapeutic Devices
by Product Segment - Diagnostic Devices (Clinical/Fixed PSG,
Ambulatory PSG, and Others (Screening Devices)), and
Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and
Facial Interfaces (Masks and Humidifiers)) Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2010 through 2018 (includes corresponding Graph/Chart) III-59

Table 76: Rest of World Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices (Clinical/ Fixed PSG, Ambulatory PSG, and
Others (Screening Devices)), and Therapeutic Devices (CPAP,
Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and
Humidifiers)) Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-60

Table 77: Rest of World 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
(Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening
Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level
PAP, and Facial Interfaces (Masks and Humidifiers)) Markets
for Years 2004, 2011, and 2018 (includes corresponding
Graph/Chart) III-61


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 68 (including Divisions/Subsidiaries - 106)

The United States (51)
Canada (4)
Japan (2)
Europe (31)
- France (4)
- Germany (8)
- The United Kingdom (5)
- Italy (2)
- Spain (3)
- Rest of Europe (9)
Asia-Pacific (Excluding Japan) (13)
Latin America (2)
Middle East (3)